Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Ticker SymbolAIFF
Company nameFirefly Neuroscience Inc
IPO dateOct 27, 1993
Founded at2021
CEOMr. Greg Lipschitz
Number of employees13
Security typeOrdinary Share
Fiscal year-endOct 27
Address1100 Military Road
CityKENMORE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code14217
Phone18882376412
Websitehttps://fireflyneuro.com/
Ticker SymbolAIFF
IPO dateOct 27, 1993
Founded at2021
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data